Log in with your email address username.


[Correspondence] Is discussion of dengue vaccination for the 2016 Olympics necessary?

Scott Halstead and Maira Aguiar1 ask if visitors to the 2016 Olympic Games in Rio de Janeiro might be tempted to obtain dengue vaccination (Dengvaxia) through the private market in Brazil. They state that Dengvaxia might not protect flavivirus-naive individuals, and that vaccination in children aged 2–5 years could increase their risk of hospital admission for breakthrough dengue infection. First, in Brazil, Dengvaxia is indicated for prevention of dengue disease caused by the four dengue serotypes in individuals aged 9–45 years living in endemic areas.